Vor Biopharma Inc.
VOR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $325,537 | $202,940 | $89,561 | $76,263 |
| - Cash | $160,462 | $190,574 | $50,047 | $81,949 |
| + Debt | $3,059 | $0 | $30,782 | $31,830 |
| Enterprise Value | $168,134 | $12,366 | $70,296 | $26,144 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$865 |
| % Margin | – | – | – | – |
| EBITDA | -$812,682 | -$241,513 | -$32,466 | -$29,847 |
| % Margin | – | – | – | – |
| Net Income | -$812,684 | -$1,573,669 | -$32,486 | -$30,712 |
| % Margin | – | – | – | – |
| EPS Diluted | -121.63 | -251.2 | -5.2 | -9 |
| % Growth | 51.6% | -4,730.8% | 42.2% | – |
| Operating Cash Flow | -$53,662 | -$35,184 | -$31,066 | -$24,063 |
| Capital Expenditures | -$244 | -$152 | -$231 | -$72 |
| Free Cash Flow | -$53,906 | -$35,336 | -$31,297 | -$24,135 |